Improved therapeutic index of an acidic pH-selective antibody

Although therapeutically efficacious, ipilimumab can exhibit dose-limiting toxicity that prevents maximal efficacious clinical outcomes and can lead to discontinuation of treatment. We hypothesized that an acidic pH-selective ipilimumab (pH Ipi), which preferentially and reversibly targets the acidi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peter S. Lee (Autor), Katherine G. MacDonald (Autor), Evan Massi (Autor), Pamela V. Chew (Autor), Christine Bee (Autor), Padma Perkins (Autor), Bryant Chau (Autor), Kent Thudium (Autor), Jack Lohre (Autor), Pradyot Nandi (Autor), Ekaterina G. Deyanova (Autor), Ishita Barman (Autor), Olafur Gudmundsson (Autor), Gavin Dollinger (Autor), Tim Sproul (Autor), John J. Engelhardt (Autor), Pavel Strop (Autor), Arvind Rajpal (Autor)
Formato: Libro
Publicado: Taylor & Francis Group, 2022-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible